Online ISSN: 1949-2553
www.oncotarget.com
About Oncotarget
Our mission is to make scientific results rapidly and widely available. We seek to maximize the impact of research via insightful review, to enable exceptional discoveries to be shared quickly, to eliminate the border between specialties, to link different fields of biomedical science, and to foster application of basic and clinical science to fight disease.

LEARN MORE ABOUT ONCOTARGET

Table of Contents: Oncotarget’s Volume 12, Issue #11

Oncotarget

May 25, 2021
Read short summaries of the latest oncology-focused research published in this week’s issue of Oncotarget, Volume 12, Issue 11. continue reading »

Special Collections by Oncotarget: Skin Cancer & Melanoma

Oncotarget

May 20, 2021
Oncotarget launched a new Special Collection of scientific publications directly related to skin cancer and melanoma research. continue reading »

Trending With Impact: RNA Modification Regulatory Proteins in Melanoma

Oncotarget

May 20, 2021
Researchers analyzed various publicly available datasets and identified two RNA modification regulatory proteins that are not only upregulated in melanoma, but necessary for melanoma growth. continue reading »

Impact Journals to Present on Scientific Integrity at SSP Annual Meeting

Oncotarget

May 19, 2021
Impact Journals is an exhibitor/sponsor and will be presenting its scientific integrity process at the Society for Scholarly Publishing (SSP) Annual Meeting, occurring virtually from May 24-27, 2021. continue reading »

Behind the Study: Potential Therapeutic Target in Breast Cancer Cells

Oncotarget

May 17, 2021
Dr. John Hawse from the Mayo Clinic in Minnesota, U.S., discusses his 2017 study published by Oncotarget, entitled, "ERβ inhibits cyclin dependent kinases 1 and 7 in triple negative breast cancer." continue reading »